You are here

  • Home
  • Archive
  • Volume 11, Issue 3
  • All-trans retinoic acid improves NSD2-mediated RARα phase separation and efficacy of anti-CD38 CAR T-cell therapy in multiple myeloma

Article metrics

Article menu
Immune cell therapies and immune cell engineering
Original research
All-trans retinoic acid improves NSD2-mediated RARα phase separation and efficacy of anti-CD38 CAR T-cell therapy in multiple myeloma

 

Online download statistics by month:

Online download statistics by month: March 2023 to January 2026

AbstractFullPdf
Mar 2023355363146
Apr 202316116177
May 202312312453
Jun 202312612665
Jul 202311711757
Aug 202317317743
Sep 2023909036
Oct 202310110150
Nov 2023949442
Dec 2023828357
Jan 202410710776
Feb 2024666836
Mar 2024127129110
Apr 2024868858
May 2024757644
Jun 2024828142
Jul 202413313453
Aug 2024525129
Sep 2024103103293
Oct 2024919243
Nov 2024878848
Dec 202415315683
Jan 2025155155127
Feb 202523123162
Mar 2025979769
Apr 202510911073
May 2025838332
Jun 2025696936
Jul 2025110
Sep 2025660
Jan 2026001
Total333533611941